1.62
Aptevo Therapeutics Inc (APVO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Research and Development |
5.81%
3.696
|
3.924 | 3.535 | 4.044 | 3.328 |
| Operating Income/Loss |
5.76%
-6.443
|
-6.837 | -5.996 | -7.61 | -6.226 |
| Income/Loss From Continuing Operations After Tax |
5.09%
-6.356
|
-6.697 | - | -7.549 | -6.204 |
|
|
5.09%
-6.356
|
-6.697 | -5.806 | -7.549 | -6.204 |
| Basic Average Shares |
12.79%
1.1964
|
1.0607 | - | 4.049 | 0.7381 |
| Diluted Average Shares |
12.79%
1.1964
|
1.0607 | - | 4.049 | 0.7381 |
| Basic Earnings Per Share |
17.16%
-5.31
|
-6.41 | - | -2.23 | -8.40 |
| Diluted Earnings Per Share |
17.16%
-5.31
|
-6.41 | - | -2.23 | -8.40 |
大文字化:
|
ボリューム (24 時間):